Good Morning! Beneath are a number of the major technological startup information of at this time, Monday, December 9, 2019.
Amazon blames President Trump for dropping a $ 10 billion JEDI cloud contract with Microsoft. Let the blame recreation start. Amazon Internet Companies (AWS), a subsidiary of Amazon, says it didn’t win the JEDI contract, because of repeated private and non-private assaults by President Donald Trump in opposition to Amazon and its CEO, Jeff Bezos, in response to a brand new presentation made public at this time AWS now It’s asking the Division of Protection to rescind the award of the contract, which might be price as much as $ 10 billion, and to make one other evaluate of the proposals offered. The corporate additionally argues that Trump "didn’t cover his private disgust" for Bezos in criticizing him publicly after which "used his workplace" to forestall AWS from profitable the contract. The presentation is a part of a really drafted 103-page doc that was made public on Monday.
The WalkMe digital adoption platform obtains $ 90 million in funds to scale operations and increase to Latin America. WalkMe, a digital adoption platform based mostly in San Francisco, California, closed a $ 90 million spherical of financing to proceed increasing operations and increasing its business attain to new markets, together with Latin America. The spherical, which introduced whole funds raised up to now to greater than $ 307 million, was led by Vitruvian Companions with the participation of Perception Companions. Co-founded by President Rafael Sweary, WalkMe provides a digital adoption platform that simplifies the consumer expertise and drives motion utilizing information, dedication, steering and automation capabilities.
Centana launches a second fund of $ 375 million to put money into high-growth fintech startups. Centana Development Companions, a progress capital agency targeted on the way forward for monetary companies, has closed $ 375 million for its second fund, Centana Development Companions II, LP (“Fund II”) to increase its investments in progressive corporations and Excessive progress all through the nation. ecosystem of monetary companies. Fund II is a follow-up that’s 50% bigger than its inaugural 2015 fund. Based in 2015 by Ben Cukier and Eric Byunn, Centana Development Companions, based mostly in New York and Palo Alto, California, gives progress capital and enterprise capital to corporations within the monetary companies sector. Centana invests in fast-growing corporations all through the monetary companies trade, from banking to insurance coverage and funds, placing $ 5 million to $ 30 million at every begin.
Fintech FlexPay startup will get $ 6 million in funds. FlexPay, an organization based mostly in Montreal, Canada, that makes use of synthetic intelligence and machine studying to allow retailers to recuperate misplaced income from rejected transactions, has secured $ 6 million in funds to increase operations and business attain. The spherical was led by Impression Ventures, with the participation of BMO Capital Companions, Anges Québec and strategic companions. Led by Darryl Hicks, CEO, FlexPay provides synthetic intelligence-driven decline restoration charges for e-commerce subscription based mostly retailers, combining expertise with proprietary knowledge. The platform leverages synthetic intelligence and machine studying to investigate billions of transaction data to reverse engineer precisely why danger mitigation methods are falsely lowering transactions.
The biotechnology startup Gelesis raises over $ 84 million to assist the launch in the USA of Plenity, a drug for the therapy of weight problems and different persistent gastrointestinal ailments. Gelesis, a Boston-based biotechnology startup that develops therapies to soundly deal with overweight, obese and diabetic sufferers, introduced that it has secured $ 84.6 million in new funds to assist the launch of Plenity in the USA within the second mid-2020. This final spherical of capital funds, totaling $ 63.four million, was led by non-public fairness agency Vitruvian Companions and included different buyers. Gelesis has raised nearly $ 100 million this yr to assist the launch in the USA of its flagship product Plenity. Gelesis was co-founded in 2006 by Yishai Zohar and PureTech Well being, a scientific stage biotechnology firm devoted to discovering, creating and advertising and marketing extremely differentiated medication for devastating ailments. Its major product, Gelesis100, is a brilliant orally administered capsule that’s manufactured with supplies that the Meals and Drug Administration (FDA) acknowledges as Common Protected (GRAS).